Summary |
|
||||||||||||
Variant origin |
|
||||||||||||
Variant description |
|
||||||||||||
Notes |
Mapping and Phenotype information for this QTL, its variants and associated markersJ:28058The authors analyzed six mouse strains for susceptibility to (beta)-carboline induced seizures, of which only two gave significant results. In one strain, Je/LeGnc, theauthors detected an association between Bis1 and je. Analysis of (C3XtEso/Gnc x Je/LeGnc)F1 backcross and intercross progeny confirmed the mapping of Bis1 to within ~3.1 cM of je on mouse Chromsome 4. J:54925The authors examined the gentic basis of differences in seizure behaviour using a GABAa receptor agoinst beta CCM (methyl beta-carboline-3 carboxylate). A/J mice are more susceptible to beta-CCM induced myoclonic seizures than C57BL/6J mice in both latency to seizure and proportion of tested mice that seized. The previously identified Bis1 QTL was confirmed in a subsequent backcross population (n = 223), D4Mit68 on distal Chromosome 4 is associated with seizure susceptibility (chi square = 10.3; p<0.0012; n = 217) and seizure latency. A LOD score = 2.88 was assigned to this locus and it accounted for 6-9% of the phenotypic variance for this seizure trait. The best-fitting logistic regression model suggests that the C57BL/6J allele at the D4Mit68 locus increased the likelihood of resistance to seizures at 23 fold. Candidate genes in this region include Htr1da, Htr1db and Slc9a1. |
||||||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|